|
FARSB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92541999999296E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.90709999999506E-05 |
| Normal-vs-Stage2 |
1.520030E-01 |
| Normal-vs-Stage3 |
2.2493999999984E-05 |
| Normal-vs-Stage4 |
1.00540000003146E-06 |
| Stage1-vs-Stage2 |
1.836380E-01 |
| Stage1-vs-Stage3 |
2.395000E-01 |
| Stage1-vs-Stage4 |
5.938100E-02 |
| Stage2-vs-Stage3 |
5.363800E-02 |
| Stage2-vs-Stage4 |
2.006300E-02 |
| Stage3-vs-Stage4 |
5.720400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21450000015678E-07 |
| Normal-vs-AfricanAmerican |
3.617600E-01 |
| Normal-vs-Asian |
3.078800E-03 |
| Caucasian-vs-AfricanAmerican |
5.995600E-02 |
| Caucasian-vs-Asian |
4.023800E-01 |
| AfricanAmerican-vs-Asian |
2.640000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24529999999223E-05 |
| Normal-vs-Female |
8.00310000000914E-05 |
| Male-vs-Female |
2.448600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.12600000000429E-05 |
| Normal-vs-Age(41-60Yrs) |
9.10729999969995E-07 |
| Normal-vs-Age(61-80Yrs) |
3.921800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.273390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.922800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.552000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.221600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.066350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.387600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.319400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.278190E-01 |
| Classical-VS-Follicular |
2.758400E-03 |
| Classical-VS-Other |
3.365000E-01 |
| Classical-VS-Normal |
2.4636999999994E-05 |
| Tall-VS-Follicular |
6.317900E-03 |
| Tall-VS-Other |
8.920600E-01 |
| Tall-VS-Normal |
6.18919999999523E-05 |
| Follicular-VS-Other |
1.114750E-01 |
| Follicular-VS-Normal |
5.226000E-01 |
| Other-VS-Normal |
5.057800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.924710E-03 |
| Normal-vs-N1 |
1.20690000215973E-08 |
| N0-vs-N1 |
2.624100E-04 |
|
|
